In a number of developing nations, besides shortages of health professionals and facilities, an increasing number of patients have been suffering in recent years from non-communicable diseases (NCDs) such as cancer, diabetes, and renal diseases, as well as from infectious diseases. Due to a lack of adequate measures in place to control NCDs – in respect of which prevention, early detection, and early treatment are important – there are concerns over reduced quality of life in patients and economic burdens from increased healthcare expenditures.
Against this background, Sysmex has focused on urinalysis, which can be used to screen for NCDs with minimal burden on patients, and has been working to increase use of urinalysis testing through automation of the urinalysis process. In 2018, the company’s proposal on “Dissemination of Automated Urinalysis Diagnosis Technology in the Republic of Ghana” was selected as a project under JICA’s Collaboration Program with the Private Sector for Disseminating Japanese Technology for Social and Economic Development of Developing Countries (current program name: “SDGs Business Supporting Surveys”). Since then, it has carried forward activities based on partnerships with JICA and the local Health Ministry and hospitals. It is in recognition of these activities as a commitment to attainment of SDGs that JICA has designated Sysmex a “JICA-SDGs Partner.”
Going forward, Sysmex will continue to instill confidence in customers, both in developing countries and globally, by contributing to attainment of SDGs as well through addressing challenges in healthcare by way of the company’s products and services.